Absolute Markets Insights (AMI) reports a robust forecast for the global platelet rich plasma market during the 2021-2029 period. In its newly released report, AMI anticipates the market will grow at a CAGR of 15.65% over the forecast period. The COVID-19 pandemic has caused significant disruption in the lives of individuals globally. Researchers are working on new treatment methods that can effectively cure the ailments associated with coronavirus, and experiments involving platelet rich plasma is on the rise in regions like North America, Europe and Asia Pacific. Aljazeera Hospital, for instance, sponsored a research that was conducted on individuals between the age group of 20 Years to 70 Years that involved the use of platelet rich plasma for treatment of COVID-19 effects. The virus is known to lead to a spike in proinflammatory cytokine levels, and leads to a phenomenon known as cytokine storm, which is also referred to as cytokine release syndrome (CRS). Activated platelet rich plasma has the ability to counter cytokine release syndrome (CRS) in humans, due to the presence of various growth factors and anti-inflammatory cytokines. Therefore, the use of platelet rich plasma for the treatment of COVID-19 patients is expected to further the growth of the global platelet rich plasma market during the forecast years.
Access the Full Report @ https://www.absolutemarketsinsights.com/reports/Global-Platelet-Rich-Plasma-Market-2021—2029-918
AMI reported that sports medicine applications of platelet rich plasma market will see considerable growth during the forecast years, driven by the rise in awareness about the therapy amongst sports medicine experts, and the growing demand for faster healing of injuries to prolong sports career amongst athletes. Tissue repair can be accelerated with the help of plasma rich therapy, and this field of regenerative medicine is receiving considerable attention from various sports clubs and athletes across the globe. Critical mechanisms such as inflammation, extracellular matrix synthesis, and angiogenesis can be influenced using platelet rich plasma therapy. However, continuous effort is required to monitor the progress of PRP treatment, as the response to this therapy is highly individualized. The treatment of cartilage injuries, which remains a daunting obstacle for medical professionals, is being increasingly explored using regenerative therapies such as platelet rich plasma therapy and gene therapy.
Some of key players operating in the global platelet rich plasma market are Atlas Health Medical Group, DePuySynthes, EmCyte Corporation, Glofinn America, LLC, Stryker, Terumo BCT, Inc., Zimmer Biomet, Medsor Impex, AdvaCare Pharma, PRP Labs, amongst others.
Global Platelet Rich Plasma Market
By Type
- Pure Platelet-Rich Plasma or Pure PRP (P-PRP)
- Leukocyte and Platelet-Rich Plasma (L-PRP)
- Pure Platelet-Rich Fibrin (P-PRF)
- Leukocyte and Platelet-Rich Fibrin (L-PRF)
By Application
- Orthopaedics
- Sports medicine
- Wound healing
- Aesthetic surgery
- Dentistry
- Otolaryngology
- Neurosurgery
- Ophthalmology
- Urology
- Prolotherapy
- Cardiothoracic
- Maxillofacial surgery
- Others
By End Use
- Hospitals
- Clinics
- Others
By Region
- North America
-
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
-
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
-
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
-
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
-
- Brazil
- Argentina
- Rest of Latin America
Contact Us:
Company: Absolute Markets Insights
Email id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
Website: https://www.absolutemarketsinsights.com